ADVERTISEMENT
Can.cer therapies often rely on boosting the immune system so it can better detect and destroy can.cer cells.
One approach uses immune checkpoint inhibitors (ICIs), drugs proven effective against can.cers like lung can.cer and melanoma.
However, not all patients respond well to ICIs, leading scientists to look for ways to improve their effectiveness.
That’s where castalagin comes in. Researchers found that this compound can alter the gut microbiome — the complex ecosystem of bacteria in our digestive system — in ways that strengthen immune response.
Castalagin could potentially boost the immune system and improve the success of ICIs in can.cer treatment.
From Mice to Humans: The Research Progresses
ADVERTISEMENT
ADVERTISEMENT
